Physician

Priyank Desai, M.D.

According to 2025 Medicare claims, Priyank Desai, M.D. (NPI: 1316148794) practices pulmonary disease in the Rocky Mount, NC market, with the plurality of this provider's patient population coming from Nash, NC. This provider's primary affiliated billing organization is BOICE-WILLIS CLINIC PA (NPI: 1699722389; TIN: 561025986) and primary practice location at 27804-8467. Desai is affiliated with the The Accountable Care Organization, Ltd. (ACO ID: A2098), participating under the MSSP model.

Desai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 700 traditional Medicare patients, billed 3,365 HCPCS/CPT codes, and received $248,730 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,183 prescription claims across 552 beneficiaries totaling $2,700,539 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,243 claims. Open Payments data shows 78 records totaling $89,066. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $498,811 to $248,730. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, reported payments rose steadily, from $73,505 to $103,067.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,068	6,172	$498,811
2016	1,382	11,970	$785,397
2017	1,308	8,252	$640,096
2018	1,352	9,970	$703,357
2019	1,310	9,259	$633,490
2020	1,116	8,270	$588,731
2021	945	4,625	$340,672
2022	924	5,054	$314,783
2023	763	6,406	$293,760
2024	700	3,365	$248,730

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	415	2,745	$1,010,939
2016	534	3,412	$1,359,188
2017	525	2,901	$2,950,858
2018	607	3,503	$2,843,285
2019	763	4,269	$2,780,251
2020	669	3,382	$2,705,015
2021	595	2,814	$2,118,667
2022	537	2,686	$2,252,244
2023	488	2,633	$2,352,660
2024	552	3,183	$2,700,539

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	263	1,152	$102,532
2016	459	1,941	$137,976
2017	536	2,138	$131,223
2018	418	1,613	$89,295
2019	429	2,003	$141,501
2020	475	2,219	$208,391
2021	372	1,863	$176,961
2022	325	1,358	$159,651
2023	198	1,099	$136,393
2024	212	1,243	$141,653

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	232	348	$87
94727	Test to determine lung volumes using gas dilution or washout	250	251	$31
94729	Test to examine how well the lungs exchange gases	327	329	$31
94010	Test to measure expiratory airflow and volume	242	243	$17
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	157	193	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	929	31,920	$677,264
Ofev	Nintedanib Esylate	30	1,140	$495,453
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	416	14,364	$300,266
Tezspire	Tezepelumab-Ekko	36	1,030	$158,462
Prolastin C	Alpha-1-Proteinase Inhibitor	13	357	$117,025

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	47	$47,581
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	44	$33,485
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	43	320	$30,029
E1392	Portable oxygen concentrator, rental	Y	24	172	$6,101
J7605	Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms	N	N/R	61	$4,195

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	61	$13,345	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	17	$75,721	GlaxoSmithKline, LLC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Priyank Desai, M.D.?

Tedicare shows public-source Medicare data for Priyank Desai, M.D. (NPI 1316148794), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Priyank Desai, M.D. have ACO affiliation data?

Priyank Desai, M.D. is shown with ACO affiliation data for The Accountable Care Organization, Ltd. (MSSP, ACO ID A2098).

What billing organization is linked to Priyank Desai, M.D.?

Priyank Desai, M.D. is linked to BOICE-WILLIS CLINIC PA (billing NPI 1699722389) in the available physician profile data.

Does Priyank Desai, M.D. have Open Payments data?

Priyank Desai, M.D. has 78 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.